| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |